Dapagliflozin and Metformin Extended-Release Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Dapagliflozin and Metformin Extended-Release Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dapagliflozin / metformin
Brand name: Xigduo XR
Synonyms: Dapagliflozin and metformin, Dapagliflozin and Metformin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dapagliflozin and Metformin Extended-Release Tablets-Molindone
- Dapagliflozin and Metformin Extended-Release Tablets-Mometasone (Oral Inhalation)
- Dapagliflozin and Metformin Extended-Release Tablets-Mometasone and Formoterol
- Dapagliflozin and Metformin Extended-Release Tablets-Mometasone and formoterol Inhalation
- Dapagliflozin and Metformin Extended-Release Tablets-Mometasone Cream
- Dapagliflozin and Metformin Extended-Release Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Dapagliflozin and saxagliptin
- Mogamulizumab-kpkc Intravenous-Dapagliflozin Propanediol
- Mogamulizumab-kpkc Intravenous-Dapsone
- Mogamulizumab-kpkc Intravenous-Dapsone (Systemic)
- Mogamulizumab-kpkc Intravenous-Dapsone Gel
- Mogamulizumab-kpkc Intravenous-Dapsone topical